In today’s briefing:
- Wuxi Biologics Placement – Lesser Discount than Recent Deals but Still Looks Good
- AInnovation Technology Lock-Up – US$670m Worth of Pre-IPO Investment Is Still Well in the Money
Wuxi Biologics Placement – Lesser Discount than Recent Deals but Still Looks Good
- Wuxi Biologics Holdings is looking to raise up to US$513m by selling about 1.3% of Wuxi Biologics (2269 HK).
- This is the company’s 16th placement since it listed in June 2017.
- In this note, we will discuss deal dynamics, past deal performance, and share the scores on our ECM framework.
AInnovation Technology Lock-Up – US$670m Worth of Pre-IPO Investment Is Still Well in the Money
- Qingdao Ainnovation Technology Group (2121 HK) was listed on 27th Jan 2022, with its one-year lockup expiring on 27th January 2023.
- Qingdao AInnovation Technology Group is an AI solutions provider offering full-stack AI-based products and solutions.
- Coming up for one-year lockup expiry are the pre-IPO shareholders. Bulk of them are in the money as some have invested as early as 2018.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
